{"id":3527,"date":"2022-07-22T11:01:37","date_gmt":"2022-07-22T01:01:37","guid":{"rendered":"\/eu-uk\/?p=3527"},"modified":"2022-07-26T11:04:14","modified_gmt":"2022-07-26T01:04:14","slug":"dr-borehams-crucible-july-2022","status":"publish","type":"post","link":"\/eu-uk\/blog\/2022\/07\/22\/dr-borehams-crucible-july-2022\/","title":{"rendered":"Dr Boreham\u2019s Crucible | July 2022"},"content":{"rendered":"<p>Orthocell has been featured in the widely read column, Dr Boreham\u2019s Crucible. The column, which appeared in Biotech Daily, is written by respected small cap analyst and business journalist, Tim Boreham.<\/p>\n<p>Tim\u2019s commentary follows the recent execution of a global exclusive licence and distribution agreement with BioHorizons Implant Systems Inc for Orthocell\u2019s Striate+\u2122 dental membrane.<\/p>\n<p>Tim Boreham wrote:<\/p>\n<p><em>\u201cGiven the current unsympathetic market conditions, any biotech that tries to raise equity will suffer the equivalent of being stabbed in the eye with a syringe.<\/em><\/p>\n<p><em>Other non-dilutive funding sources are vital, which explains the outbreak of investor joy at Orthocell\u2019s deal in late June to sell the rights to its dental regenerative tool for $23.1 million.\u201d<\/em><\/p>\n<p><a href=\"https:\/\/www.biotechdaily.com.au\/wp\/wp-content\/uploads\/sites\/6\/2022\/07\/OCC-Jul-22..pdf\"><strong>Read Dr Boreham\u2019s Crucible here.<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell was featured in the widely read column, Dr Boreham\u2019s Crucible, written by respected small cap analyst and business journalist, Tim Boreham.\u00a0<\/p>\n","protected":false},"author":2,"featured_media":3528,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-3527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/3527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=3527"}],"version-history":[{"count":3,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/3527\/revisions"}],"predecessor-version":[{"id":3532,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/3527\/revisions\/3532"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/3528"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=3527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=3527"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=3527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}